{"entity":{"type":"insider","cik":"0001546358","url":"/insider/0001546358","json_url":"/insider/0001546358.json","name":"Consylman Gina","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":38,"n_filings":18,"first":"2013-10-07","last":"2021-03-02","span_basis":"filed_date"},"name_variants":[{"name":"Consylman Gina","source":"filing","n_filings":18,"first_seen":"2013-10-07","last_seen":"2021-03-02"}],"transactions":[{"id":5244751,"accession":"0001209191-21-016018","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-016018","line_url":"/filing/0001209191-21-016018","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18406.0,"shares_display":"18,406","price_per_share":9.11,"price_display":"9.11","price_state":"stated","total_value":167678.66,"total_display":"167,678.66","total_whole":"167,679","shares_owned_after":336244.0,"shares_owned_after_display":"336,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-26","filed_date":"2021-03-02","scope":"insider","n_lines":4},{"id":3018992,"accession":"0001209191-20-057600","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-057600","line_url":"/filing/0001209191-20-057600","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1415.0,"shares_display":"1,415","price_per_share":10.92,"price_display":"10.92","price_state":"stated","total_value":15451.8,"total_display":"15,451.80","total_whole":"15,452","shares_owned_after":270289.0,"shares_owned_after_display":"270,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-10","scope":"insider","n_lines":2},{"id":2679665,"accession":"0001209191-20-012474","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-012474","line_url":"/filing/0001209191-20-012474","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12501.0,"shares_display":"12,501","price_per_share":11.63,"price_display":"11.63","price_state":"stated","total_value":145386.63,"total_display":"145,386.63","total_whole":"145,387","shares_owned_after":202787.0,"shares_owned_after_display":"202,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-21","filed_date":"2020-02-25","scope":"insider","n_lines":4},{"id":8010982,"accession":"0001209191-19-056188","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-056188","line_url":"/filing/0001209191-19-056188","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1510.0,"shares_display":"1,510","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":16610.0,"total_display":"16,610.00","total_whole":"16,610","shares_owned_after":174768.0,"shares_owned_after_display":"174,768","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-08","filed_date":"2019-11-12","scope":"insider","n_lines":2},{"id":7789937,"accession":"0001209191-19-046846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-046846","line_url":"/filing/0001209191-19-046846#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":212.0,"shares_display":"212","price_per_share":9.04,"price_display":"9.04","price_state":"stated","total_value":1916.48,"total_display":"1,916.48","total_whole":"1,916","shares_owned_after":175648.0,"shares_owned_after_display":"175,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-16","filed_date":"2019-08-20","scope":"insider"},{"id":8646038,"accession":"0001209191-19-029596","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-029596","line_url":"/filing/0001209191-19-029596#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4055.0,"shares_display":"4,055","price_per_share":10.53,"price_display":"10.53","price_state":"stated","total_value":42699.15,"total_display":"42,699.15","total_whole":"42,699","shares_owned_after":175860.0,"shares_owned_after_display":"175,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-10","filed_date":"2019-05-14","scope":"insider"},{"id":8692032,"accession":"0001209191-19-012630","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-19-012630","line_url":"/filing/0001209191-19-012630","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46.0,"shares_display":"46","price_per_share":14.32,"price_display":"14.32","price_state":"stated","total_value":658.72,"total_display":"658.72","total_whole":"659","shares_owned_after":163184.0,"shares_owned_after_display":"163,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-21","filed_date":"2019-02-22","scope":"insider","n_lines":4},{"id":8692018,"accession":"0001209191-19-012630","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-012630","line_url":"/filing/0001209191-19-012630","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5631.0,"shares_display":"5,631","price_per_share":14.31,"price_display":"14.31","price_state":"stated","total_value":80579.61,"total_display":"80,579.61","total_whole":"80,580","shares_owned_after":163230.0,"shares_owned_after_display":"163,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-20","filed_date":"2019-02-22","scope":"insider","n_lines":4},{"id":6765818,"accession":"0001209191-18-058419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-058419","line_url":"/filing/0001209191-18-058419#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1358.0,"shares_display":"1,358","price_per_share":11.81,"price_display":"11.81","price_state":"stated","total_value":16037.98,"total_display":"16,037.98","total_whole":"16,038","shares_owned_after":96361.0,"shares_owned_after_display":"96,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-09","filed_date":"2018-11-13","scope":"insider"},{"id":6426045,"accession":"0001209191-18-047765","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-047765","line_url":"/filing/0001209191-18-047765#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":188.0,"shares_display":"188","price_per_share":18.21,"price_display":"18.21","price_state":"stated","total_value":3423.48,"total_display":"3,423.48","total_whole":"3,423","shares_owned_after":97719.0,"shares_owned_after_display":"97,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-17","filed_date":"2018-08-21","scope":"insider"},{"id":6075501,"accession":"0001209191-18-012571","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-012571","line_url":"/filing/0001209191-18-012571","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3594.0,"shares_display":"3,594","price_per_share":14.66,"price_display":"14.66","price_state":"stated","total_value":52688.04,"total_display":"52,688.04","total_whole":"52,688","shares_owned_after":55907.0,"shares_owned_after_display":"55,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-21","filed_date":"2018-02-22","scope":"insider","n_lines":3},{"id":5076418,"accession":"0001209191-17-060593","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-060593","line_url":"/filing/0001209191-17-060593#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (Interim CFO and CAO)","role_mark":"O","role_mark_label":"Officer (Interim CFO and CAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CFO and CAO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":864.0,"shares_display":"864","price_per_share":15.2,"price_display":"15.20","price_state":"stated","total_value":13132.8,"total_display":"13,132.80","total_whole":"13,133","shares_owned_after":52001.0,"shares_owned_after_display":"52,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-10","filed_date":"2017-11-14","scope":"insider"},{"id":5320202,"accession":"0001209191-17-049809","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-049809","line_url":"/filing/0001209191-17-049809#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":207.0,"shares_display":"207","price_per_share":14.34,"price_display":"14.34","price_state":"stated","total_value":2968.38,"total_display":"2,968.38","total_whole":"2,968","shares_owned_after":52865.0,"shares_owned_after_display":"52,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-18","filed_date":"2017-08-22","scope":"insider"},{"id":4154763,"accession":"0001209191-17-015221","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-015221","line_url":"/filing/0001209191-17-015221#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2962.0,"shares_display":"2,962","price_per_share":16.53,"price_display":"16.53","price_state":"stated","total_value":48961.86,"total_display":"48,961.86","total_whole":"48,962","shares_owned_after":26822.0,"shares_owned_after_display":"26,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-24","filed_date":"2017-02-28","scope":"insider"},{"id":4733532,"accession":"0001209191-17-014354","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-014354","line_url":"/filing/0001209191-17-014354","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1839.0,"shares_display":"1,839","price_per_share":16.94,"price_display":"16.94","price_state":"stated","total_value":31152.66,"total_display":"31,152.66","total_whole":"31,153","shares_owned_after":29784.0,"shares_owned_after_display":"29,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-22","filed_date":"2017-02-24","scope":"insider","n_lines":2},{"id":2961358,"accession":"0001209191-16-138149","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-138149","line_url":"/filing/0001209191-16-138149#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":207.0,"shares_display":"207","price_per_share":13.54,"price_display":"13.54","price_state":"stated","total_value":2802.78,"total_display":"2,802.78","total_whole":"2,803","shares_owned_after":21123.0,"shares_owned_after_display":"21,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-19","filed_date":"2016-08-22","scope":"insider"},{"id":2411668,"accession":"0001209191-16-103054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-103054","line_url":"/filing/0001209191-16-103054#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":420.0,"shares_display":"420","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":3570.0,"total_display":"3,570.00","total_whole":"3,570","shares_owned_after":6330.0,"shares_owned_after_display":"6,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-24","filed_date":"2016-02-26","scope":"insider"},{"id":6948583,"accession":"0001209191-14-041192","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-041192","line_url":"/filing/0001209191-14-041192","is_derivative":false,"issuer_cik":"0000006284","issuer_name":"ANALOGIC CORP","issuer_ticker":"ALOG","issuer_name_source":null,"issuer_url":"/issuer/0000006284","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (VP-Controller)","role_mark":"O","role_mark_label":"Officer (VP-Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP-Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1677.0,"shares_display":"1,677","price_per_share":74.55576428145498,"price_display":"74.56","price_state":"stated","total_value":125030.0167,"total_display":"125,030.02","total_whole":"125,030","shares_owned_after":775.0,"shares_owned_after_display":"775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-11","filed_date":"2014-06-13","scope":"insider","n_lines":2},{"id":5330960,"accession":"0001181431-13-052975","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-052975","line_url":"/filing/0001181431-13-052975","is_derivative":false,"issuer_cik":"0000006284","issuer_name":"ANALOGIC CORP","issuer_ticker":"ALOG","issuer_name_source":null,"issuer_url":"/issuer/0000006284","owner_cik":"0001546358","owner_name":"Consylman Gina","owner_display_name":"Consylman Gina","owner_url":"/insider/0001546358","role":"Officer (VP-Controller)","role_mark":"O","role_mark_label":"Officer (VP-Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP-Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1522.0,"shares_display":"1,522","price_per_share":83.14904730617609,"price_display":"83.15","price_state":"stated","total_value":126552.85,"total_display":"126,552.85","total_whole":"126,553","shares_owned_after":759.0,"shares_owned_after_display":"759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-03","filed_date":"2013-10-07","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":38,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":38,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":38},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Officer (SVP, CFO & Treasurer)","n_filings":16,"first_seen":"2016-02-26","last_seen":"2021-03-02"},{"type":"issuer","type_label":"ISSUER","cik":"0000006284","name":"ANALOGIC CORP","url":"/issuer/0000006284","role":"Officer (VP-Controller)","n_filings":2,"first_seen":"2013-10-07","last_seen":"2014-06-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001546358","retrieved_at":"2026-08-23T18:41:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}